Trial Profile
An Observational study to assess the changes in Bone mineral density after stopping Denosumab in postmenopausal women treated for atleast 7 years
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Jan 2017
Price :
$35
*
At a glance
- Drugs Denosumab (Primary)
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- 14 Jan 2017 New trial record